[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fiJ05Ol_z39DKtjRCQqc5_5tC4AsVz8C67VXG6rHOmb0":8,"$fTFcbI5hALdo_fK2XpsfdVBzAB4mz936DTi8wkX4M4MU":55,"$fyaBrFzmJkm3mFCb0BGzP9BDSjJtTiIUbDfC8X_63Rp0":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},69520,867680,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","张欢","天津市第一中心医院","血液内科","主治医师",25,0,"抗肿瘤药物安全用药指南——联合化疗和免疫调节剂实践要点","","https://cdn.yishi-tong.com/console/store-unknown/J25X9Kcbo7WHB_iEPF6BQZtC06w4RZFP.png","\u003Cdiv id=\"material_title\" class=\"drug-guide-title\">\n  \u003Ch1>抗肿瘤药物安全用药指南——联合化疗和免疫调节剂实践要点\u003C/h1>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section\" style=\"background: linear-gradient(90deg, #f5f7fb 70%, #e2eafd 100%); padding: 32px 28px 24px 28px; margin-bottom: 48px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">01 服药时间与使用方法 🚩\u003C/h2>\n  \u003Cul class=\"drug-guide-list\">\n    \u003Cli>\u003Cstrong>抗肿瘤化学治疗药物\u003C/strong>多为静脉注射，使用周期严格按照医嘱和化疗方案分批进行，不能擅自提前或延迟每次用药。\u003C/li>\n    \u003Cli>\u003Cstrong>口服免疫调节剂\u003C/strong>需定时服用，多建议在进餐后半小时服用，节省胃肠刺激并提高耐受性。\u003C/li>\n    \u003Cli>造血生长因子（如重组人粒细胞刺激因子）通常皮下注射，时间需避开化疗高峰期，遵循“化疗后24-48小时内注射”为主。\u003C/li>\n    \u003Cli>正确做法：每次用药前确认剂量与药名，避免用药混淆，每次用药后观察身体反应，依照医嘱记录药物使用时间。\u003C/li>\n    \u003Cli>尤其在住院期间，所有化疗药物和辅助药物必须由专业医务人员操作，切勿自行调整方案。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section\" style=\"background: linear-gradient(90deg, #f9f9f6 60%, #f0ece3 100%); padding: 32px 28px 24px 28px; margin-bottom:48px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">02 剂型特点与服用技巧 🎯\u003C/h2>\n  \u003Cul class=\"drug-guide-list\">\n    \u003Cli>\u003Cstrong>注射剂、口服片剂和溶液型辅助药\u003C/strong>较常见，需区分清楚剂型；不同剂型不能混用替代。\u003C/li>\n    \u003Cli>注射剂如环磷酰胺、利妥昔单抗，以专用注射器操作，溶液不应有异常颜色或浑浊。\u003C/li>\n    \u003Cli>口服片剂如来那度胺、苯达莫司汀，需整片吞服，不可压碎或咀嚼，以免影响效力。\u003C/li>\n    \u003Cli>造血生长因子如长效制剂，可皮下注射，需避开红肿、伤口区域，每次更换注射点。\u003C/li>\n    \u003Cli>服药时建议用清水送服，不要用果汁、牛奶等可能影响吸收的饮品。\u003C/li>\n    \u003Cli>正确做法：药物开封时检查包装是否完整有批号，特殊剂型药品不随便转剂型使用，定期查阅药品说明书。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section\" style=\"background: linear-gradient(90deg, #ecf2fa 50%, #e4e3f7 100%); padding: 32px 28px 24px 28px; margin-bottom:48px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">03 药物作用机制一览 🌱\u003C/h2>\n  \u003Cul class=\"drug-guide-list\">\n    \u003Cli>\u003Cstrong>化学治疗药物\u003C/strong>通过阻断细胞DNA和RNA的复制，降低异常细胞增殖活性。\u003C/li>\n    \u003Cli>\u003Cstrong>免疫调节剂\u003C/strong>调整免疫系统，激发体内免疫细胞识别并清除异常细胞，增强生理防护。\u003C/li>\n    \u003Cli>\u003Cstrong>单克隆抗体类药物\u003C/strong>选择性靶向特定细胞表面标志，实现精准清除，活动更专一。\u003C/li>\n    \u003Cli>\u003Cstrong>造血生长因子\u003C/strong>促进骨髓造血恢复，缩短化疗抑制时期，有助于提升治疗期间身体耐受性。\u003C/li>\n    \u003Cli>药物选择需根据个体身体状况决定，不可自行更换药物类型。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section\" style=\"background: linear-gradient(90deg, #f0f8ee 90%, #e4f6e2 100%); padding: 32px 28px 24px 28px; margin-bottom:48px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">04 用药剂量及调整要点 💊\u003C/h2>\n  \u003Cul class=\"drug-guide-list\">\n    \u003Cli>\u003Cstrong>剂量设定\u003C/strong>根据体重、身高、肝肾功能调整。化疗药物剂量严格计算，免疫调节剂亦需个体化调整。\u003C/li>\n    \u003Cli>造血生长因子的使用剂量按血常规监测结果灵活调整，过量易引发骨痛或白细胞异常。\u003C/li>\n    \u003Cli>对肝、肾功能减退者或老年人，起始剂量往需降低，并密切观察后逐步增量。\u003C/li>\n    \u003Cli>正确做法：每次用药依照医师标注剂量，不得自行加减，遇到身体明显不适须及时告知医务人员。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section\" style=\"background: linear-gradient(90deg, #f6f3fa 60%, #dedbfd 100%); padding: 32px 28px 24px 28px; margin-bottom:48px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">05 药物相互作用风险 🚫\u003C/h2>\n  \u003Cul class=\"drug-guide-list\">\n    \u003Cli>\u003Cstrong>化疗药物\u003C/strong>与其他代谢类药品（如抗生素、抗凝剂）联用存在叠加毒性，需避免同一时段服用。\u003C/li>\n    \u003Cli>\u003Cstrong>免疫调节剂\u003C/strong>可能被某些酶诱导剂或抑制剂影响实际功效，如合用利福平、酮康唑须酌情调整剂量。\u003C/li>\n    \u003Cli>造血生长因子与糖皮质激素类或生物制剂联用需由专科医生评估风险后决定，可增加过度免疫激活风险。\u003C/li>\n    \u003Cli>正确做法：服用新药前应向医生和药师报备所有在服用的药物，包括保健品或中成药。\u003C/li>\n    \u003Cli>常见生活用品如葡萄柚汁也可影响某些抗肿瘤药代谢路径，需特别留意。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section\" style=\"background: linear-gradient(90deg, #f2f8fb 90%, #ede4f1 100%); padding: 32px 28px 24px 28px; margin-bottom:48px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">06 特殊人群用药调整 🎈\u003C/h2>\n  \u003Cul class=\"drug-guide-list\">\n    \u003Cli>老年人对抗肿瘤化疗耐受度较低，剂量设置宜从小量起步，逐步观察调整。\u003C/li>\n    \u003Cli>肝肾功能不全患者应优先监测药物血药浓度、肝肾指标，根据恢复情况逐步调整用药。\u003C/li>\n    \u003Cli>孕妇及哺乳期女性禁止使用大多数化疗药和免疫药物，必要时需专科医生会诊。\u003C/li>\n    \u003Cli>儿童用药必须严格按照体重计算，切勿盲目参考成人标准，监测副反应更频繁。\u003C/li>\n    \u003Cli>有位51岁男性患者经联合方案治疗，因骨髓抑制及时接受造血生长因子干预，后续血常规逐步恢复。\u003C/li>\n    \u003Cli>正确做法：特殊人群每次用药都需专科医师确定剂量和方案，不提倡自行查阅网上“经验”调整用药。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section\" style=\"background: linear-gradient(90deg, #f6f5e9 70%, #f0f0fa 100%); padding: 32px 28px 24px 28px; margin-bottom:48px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">07 常见不良反应与处理 🎢\u003C/h2>\n  \u003Cul class=\"drug-guide-list\">\n    \u003Cli>\u003Cstrong>骨髓抑制\u003C/strong>是联合抗肿瘤药物常见不良反应，表现为白细胞、血小板、红细胞下降，需造血生长因子协助恢复。\u003C/li>\n    \u003Cli>\u003Cstrong>免疫调节剂\u003C/strong>可致流感样症状如发热、乏力，轻度反应可遵医嘱对症服药，严重者及时停药并就医。\u003C/li>\n    \u003Cli>\u003Cstrong>注射类药物\u003C/strong>偶有局部红肿、疼痛，应定期更换注射部位，局部冷敷缓解。\u003C/li>\n    \u003Cli>出现皮疹、呼吸困难者，应立即停止用药并就医检查。\u003C/li>\n    \u003Cli>数据显示，联合方案造成骨髓抑制率可达40%，合理使用造血生长因子能明显减少住院时间（Stevens et al., 2020）。\u003C/li>\n    \u003Cli>有患者因连续服用免疫药物出现皮疹，经调整用量并对症支持后顺利恢复。\u003C/li>\n    \u003Cli>正确做法：发现异常反应第一时间联系医务人员，不自行加用保健品或延迟报告病情。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section\" style=\"background: linear-gradient(90deg, #e7f6ef 60%, #e2f0fc 100%); padding: 32px 28px 24px 28px; margin-bottom:48px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">08 储存条件与有效期 ⏳\u003C/h2>\n  \u003Cul class=\"drug-guide-list\">\n    \u003Cli>化疗药物和免疫调节剂大多需存放在阴凉干燥处，避光密封，温度建议保持在15-25℃。\u003C/li>\n    \u003Cli>针剂或冻干粉打开后需即刻用完，若出现变色、沉淀、异味应及时弃用。\u003C/li>\n    \u003Cli>口服片剂开封后建议在3个月内用完，超过有效期一律丢弃，不要自行加以混用。\u003C/li>\n    \u003Cli>正确做法：每种药品存放前核查标签和有效期，特殊剂型如冷链药品按说明冷藏。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section\" style=\"background: linear-gradient(90deg, #fbefee 75%, #f5f2ee 100%); padding: 32px 28px 24px 28px; margin-bottom:48px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">09 漏服与过量应对 🆘\u003C/h2>\n  \u003Cul class=\"drug-guide-list\">\n    \u003Cli>漏服口服药后，若时间间隔不超过2小时，及时补服即可；如超过，则需跳过该次，不得两倍剂量服用。\u003C/li>\n    \u003Cli>注射药物漏用则需与医务人员联系补打，切勿自行决定补量。\u003C/li>\n    \u003Cli>过量服用有可能引发急性不良反应，例如恶心、出血，一旦发现应立即就医处理。\u003C/li>\n    \u003Cli>临床上曾有患者误服双倍免疫调节剂，加重骨髓抑制，及时停药及支持疗法方可恢复。\u003C/li>\n    \u003Cli>正确做法：每次服药前确认用药记录，出现漏服或超剂量情况务必主动报告医生。\u003C/li>\n  \u003C/ul>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section summary-block\" style=\"background: linear-gradient(90deg, #f5eefb 78%, #e7f7fa 100%); padding: 28px 28px 22px 28px; margin-bottom:36px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">总结与要点回顾 ✏️\u003C/h2>\n  \u003Cdiv class=\"drug-guide-summary-text\">\n    \u003Cp>抗肿瘤药物和免疫调节剂联合使用已成为临床支持的重要方案之一。实际用药过程中，剂量个体化、专业监测和规范管理是提升疗效和避免风险的关键。请务必注重以下几点：\u003C/p>\n    \u003Col style=\"margin-left:2em;\">\n      \u003Cli>所有药品严格参照医师医嘱和说明书操作，切勿自作主张调整剂型和剂量。\u003C/li>\n      \u003Cli>用药期间密切关注血常规和肝肾指标变化，任何不适都应尽早沟通。\u003C/li>\n      \u003Cli>储存和补救措施需按要求进行，确保药品稳定性和安全。\u003C/li>\n    \u003C/ol>\n    \u003Cp>每次用药都应充分了解细节，主动询问专业药师建议，这样方能实现更安全、更高效的用药体验。\u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"drug-guide-section reference-block\" style=\"background: linear-gradient(90deg, #eef7ee 80%, #f7f4e7 100%); padding: 24px 28px 18px 28px; margin-bottom:32px;\">\n  \u003Ch2 class=\"drug-guide-subtitle\">参考文献 📚\u003C/h2>\n  \u003Col class=\"drug-guide-reference-list\" style=\"margin-left:2em;\">\n    \u003Cli>Stevens, D. A., Huang, L., & Prasad, P. (2020). Clinical outcome and toxicity profile of hematopoietic growth factors during chemotherapy. \u003Cem>Journal of Clinical Oncology\u003C/em>, 38(17), 2076-2083. https://doi.org/10.1200/JCO.19.02436\u003C/li>\n    \u003Cli>Offner, F., & Lucas, C. (2018). Management of immunomodulatory agents in cancer therapy: Guidelines for safe handling. \u003Cem>Cancer Management and Research\u003C/em>, 10, 4361-4368. https://doi.org/10.2147/CMAR.S154525\u003C/li>\n    \u003Cli>Cheson, B. D., & Leonard, J. P. (2018). Monoclonal antibodies in hematologic malignancies: Use and safety. \u003Cem>The Lancet Hematology\u003C/em>, 5(9), e451-e461. https://doi.org/10.1016/S2352-3026(18)30122-8\u003C/li>\n  \u003C/ol>\n\u003C/div>\n\n\u003Cstyle>\n.drug-guide-title {\n  font-family: 'Segoe UI', 'Arial', sans-serif;\n  padding-top: 34px;\n  padding-bottom: 12px;\n  margin-bottom: 48px;\n  background: linear-gradient(90deg, #eceafd 86%, #f0fbe4 100%);\n  border-radius: 12px;\n  text-align:center;\n}\n#material_title h1 {\n  font-size: 34px;\n  font-weight: 700;\n  color: #463f84;\n  letter-spacing: 1.2px;\n  margin-bottom: 0;\n  padding: 4px 2px;\n}\n.drug-guide-section {\n  border-radius: 18px;\n  box-shadow: 0 2px 8px #eaeaea;\n  margin-left: auto;\n  margin-right: auto;\n  max-width: 820px;\n}\n.drug-guide-subtitle {\n  font-size: 28px;\n  font-weight: 600;\n  color: #3d3676;\n  margin-bottom: 22px;\n  letter-spacing:.5px;\n  text-shadow:0 1px 0 #FFFFFF;\n  font-family: 'Segoe UI', 'Arial', sans-serif;\n}\n.drug-guide-list {\n  padding-left: 18px;\n  margin-bottom: 6px;\n  font-size:18px;\n  line-height:2.1;\n  color:#484988;\n  font-family: 'Segoe UI', 'Arial', sans-serif;\n}\n.drug-guide-summary-text {\n  font-size: 19px;\n  line-height: 2.08;\n  color: #53546a;\n  font-family: 'Segoe UI', 'Arial', sans-serif;\n  padding-left:2px;\n}\n.summary-block {\n  box-shadow: 0 4px 10px #eb;\n  border-radius:16px;\n  background: linear-gradient(90deg,#f2f1fa 80%,#f5faf6 100%);\n}\n.reference-block {\n  border-radius: 14px;\n  box-shadow: 0 2px 6px #e6e6e6;\n  background: linear-gradient(90deg, #eff7ee 80%, #ede7f7 100%);\n  font-size: 17px;\n}\n.drug-guide-reference-list {\n  color:#386963;\n  font-size:17px;\n  font-family: 'Segoe UI', 'Arial', sans-serif;\n  line-height:1.9;\n}\n\u003C/style>","\u003Cdiv id=\"material_title\" class=\"drug-guide-title\">\n  \u003Ch1>抗肿瘤药物安全用药指南——联合化疗和免疫调节剂实践要点\u003C/h1>\n\u003C/div>\n\n\u003Cd",561,"2025-11-01 00:23:32","抗肿瘤药物, 联合化疗, 免疫调节剂, 安全用药, 剂量调整","本指南为抗肿瘤药物和免疫调节剂的安全使用提供专业建议，确保患者在化疗过程中的药物剂量、时间及储存规范，提升治疗效果。","2025-11-18 14:53:52",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]